Orchard Therapeutics

Orchard Therapeutics

Orchard Therapeutics is a biotechnology company developing gene therapies for rare diseases.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Orchard Therapeutics funding round, August 2018
150,000,000
August 2018
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

Orchard Therapeutics

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Krystle Vermes
June 9, 2020
BioSpace
Lundbeck stated that it is optimizing its research and development organization to strengthen and advance its pipeline.
Amirah Al Idrus
June 9, 2020
FierceBiotech
In 2019, it was all systems go for Orchard Therapeutics. The company had pulled off a $200 million IPO, picked up GlaxoSmithKline's stable of rare disease gene therapies and planned to break ground on a $90 million manufacturing site in California. Now, under the wing of a new CEO, the company has reined it in.
Ben Adams
May 8, 2020
FierceBiotech
Tough times at Orchard Therapeutics as it swings the ax across staffers and facilities, phases in new pipeline advances and reduces interest in others.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.